[Recombinant factor VII in the treatment of acute hemorrhage due to esophageal varices].
Jiménez-Sáenz
M
M
Unidad de Hepatología, Hospital Universitario Virgen Macarena, Sevilla, Spain. manueljs@wanadoo.es
Romero-Castro
R
R
D001779:Blood Coagulation Factors / Q000378:metabolism; D004341:Drug Evaluation; D004932:Esophageal and Gastric Varices / Q000150:complications*; D005167:Factor VII / Q000009:adverse effects / Q000627:therapeutic use*; D015942:Factor VIIa; D006471:Gastrointestinal Hemorrhage / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D006489:Hemostatic Techniques; D006801:Humans; D017093:Liver Failure / Q000378:metabolism; D010865:Pilot Projects; D011517:Prothrombin Time; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D019851:Thrombophilia / Q000139:chemically induced
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa